Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 182

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike

Open access
Lubinski, Bailey, Fernandes, Maureen H.V., Frazier, Laura, Tang, Tiffany, Daniel, Susan, Diel, Diego G., Jaimes, Javier A., Whittaker, Gary R. · 2022 · iScience

Published version of a preprint

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent causing the COVID-19 pandemic. SARS-CoV-2 B.1.1.7 (Alpha), a WHO variant of concern first identified in the United Kingdom in late 2020, contains several mutations including P681H in the spike S1/S2 cleavage site, which is predicted to increase cleavage by furin, potentially impacting the viral cell entry. Here, we studied the role of the P681H mutation in B.1.1.7 cell entry. We performed assays using fluorogenic peptides mimicking the Wuhan-Hu-1 and B.1.1.7 S1/S2 sequence and observed no significant difference in furin cleavage. Functional assays using pseudoparticles harboring SARS-CoV-2 spikes and cell-to-cell fusion assays demonstrated no differences between Wuhan-Hu-1, B.1.1.7, or a P681H point mutant. Likewise, we observed no differences in viral growth between USA-WA1/2020 and a B.1.1.7 isolate in cell culture. Our findings suggest that, although the B.1.1.7 P681H mutation may slightly increase S1/S2 cleavage, this does not significantly impact viral entry or cell-cell spread.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.isci.2021.103589

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 30

  1. Belouzard, 2009, Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites, Proc. Natl. Acad. Sci., 106, 5871, 10.1073/pnas.0809524106 · DOI · Paper page
  2. Brown, 2021, Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape, bioRxiv
  3. Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, 395, 514, 10.1016/S0140-6736(20)30154-9 · DOI · Paper page
  4. Coutinho, 2021, Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant, Commun. Med., 1, 48, 10.1038/s43856-021-00048-6 · DOI
  5. de Oliveira, 2021, A novel variant of interest of SARS-CoV-2 with multiple spike mutations detected through travel surveillance in Africa, medRxiv
  6. Di Caro, 2021, Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations, Clin. Microbiol. Infect., 27, 823, 10.1016/j.cmi.2021.03.011 · DOI
  7. Dicken, 2021, Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2, bioRxiv
  8. Duckert, 2004, Prediction of proprotein convertase cleavage sites, Protein Eng. Des. Select., 17, 107, 10.1093/protein/gzh013 · DOI · Paper page
  9. Dudas, 2021, Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions, Nat. Commun., 12, 5769, 10.1038/s41467-021-26055-8 · DOI
  10. Follis, 2006, Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell–cell fusion but does not affect virion entry, Virology, 350, 358, 10.1016/j.virol.2006.02.003 · DOI · Paper page
  11. Goodman, 2021, Public health surveillance of infectious diseases: beyond point mutations, Lancet Microbe., 2, e53, 10.1016/S2666-5247(21)00003-3 · doi:10.1016/s2666-5247(21)00003-3
  12. Jaimes, 2020, Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop, J. Mol. Biol., 432, 3309, 10.1016/j.jmb.2020.04.009 · DOI · Paper page
  13. Jaimes, 2019, A fluorogenic peptide cleavage assay to screen for proteolytic activity: applications for coronavirus spike protein activation, J. Vis. Exp., 143, 1
  14. Jaimes, 2020, Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site, iScience, 23, 101212, 10.1016/j.isci.2020.101212 · DOI · Paper page
  15. Jin, 2020, Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site, Emerging microbes & infections, 9, 1474, 10.1080/22221751.2020.1781551 · DOI
  16. Kissler, 2021, Densely sampled viral trajectories for SARS-CoV-2 variants alpha (B.1.1.7) and epsilon (B.1.429), medRxiv
  17. Lasek-Nesselquist, 2021, A tale of three SARS-CoV-2 variants with independently acquired P681H mutations in New York State, medRxiv
  18. Liu, 2021, Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant, bioRxiv
  19. Lubinski, 2021, Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda, bioRxiv
  20. Maison, 2021, Genetic characteristics and phylogeny of 969-bp S gene sequence of SARS-CoV-2 from Hawaii reveals the worldwide emerging P681H mutation, bioRxiv
  21. Millet, 2019, Production of pseudotyped particles to study highly pathogenic coronaviruses in a biosafety level 2 setting, J. Vis. Exp., 145, 1
  22. Peacock, 2020, The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells, bioRxiv
  23. Peacock, 2021, The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin, bioRxiv
  24. Saito, 2021, SARS-CoV-2 spike P681R mutation, a hallmark of the Delta variant, enhances viral fusogenicity and pathogenicity, bioRxiv
  25. Seidah, 2012, The biology and therapeutic targeting of the proprotein convertases, Nat. Rev. Drug Discov., 11, 367, 10.1038/nrd3699 · DOI · Paper page
  26. Tang, 2021, Proteolytic activation of SARS-CoV-2 spike at the S1/S2 boundary: potential role of proteases beyond furin, ACS Infect. Dis., 7, 264, 10.1021/acsinfecdis.0c00701 · DOI
  27. Tegally, 2021, Sixteen novel lineages of SARS-CoV-2 in South Africa, Nat. Med., 27, 440, 10.1038/s41591-021-01255-3 · DOI · Paper page
  28. Tian, 2012, Computational prediction of furin cleavage sites by a hybrid method and understanding mechanism underlying diseases, Sci. Rep., 2, 261, 10.1038/srep00261 · DOI
  29. Zhang, 2021, Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant, bioRxiv, eabl9463
  30. Zhou, 2021, SARS-CoV-2 spike D614G change enhances replication and transmission, Nature, 592, 122, 10.1038/s41586-021-03361-1 · DOI · Paper page

Cited by

See all 182

Metadata

Authors
Lubinski, B., Fernandes, M. H. V., Frazier, L., Tang, T., Daniel, S., Diel, D. G., Jaimes, J. A., & Whittaker, G. R.
Venue
iScience
Publisher
Elsevier BV
Published
2022-01
Volume
25
Issue
1
Pages
103589
ISSN
2589-0042 (ISSN-L)
OpenAlex
W4200373171
Cited by
182
References
15
FWCI
12.29
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • National Science Foundation (DGE-1650441)
  • National Institutes of Health (R01AI35270)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. https://app.cochat.ai/papers/10.1016/j.isci.2021.103589
The paper
Lubinski, B., Fernandes, M. H. V., Frazier, L., Tang, T., Daniel, S., Diel, D. G., Jaimes, J. A., & Whittaker, G. R. (2022). Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. iScience. https://doi.org/10.1016/j.isci.2021.103589

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.